
About Neoventa
Neoventa is a Healthcare company based in Goteborg (Sweden) founded in 1997. Fetal monitoring solutions and services are offered for obstetric care. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Neoventa has raised $8.1 million across 1 funding round from investors including SEB, CapMan and Investor Growth Capital. Neoventa offers products and services including Stan S41, Goldtrace, and Stan Viewer. Its focus areas include Medical Devices and Fetal Monitoring. Its legal entity is Neoventa Medical AB.
Company details
Fetal monitoring technologies are developed and distributed by Neoventa Medical AB. Focus is placed on continuous monitoring devices like Stan S41 for improved maternal and fetal safety. Solutions are offered across healthcare sectors in Europe, Middle East, Asia, and Africa. Training and educational resources through Neoventa Academy are also provided to support clinical practices.
- Headquarters Goteborg, Sweden
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website neoventa.com/?doing_wp_cron=1753697927.9943768978118896484375
- Social LinkedIn
- Legal Name Neoventa Medical Ab
- Total Equity Funding$8.1M (USD)
in 1 rounds
- Latest Funding Round$8.1M (USD), Private Equity Round
Jul 2006
- InvestorsSEB
& 2 more
Products & Services of Neoventa
Neoventa offers a comprehensive portfolio of products and services, including Stan S41, Goldtrace, and Stan Viewer.
Continuous fetal monitoring is provided by this device.
Fetal monitoring support is offered through this accessory.
Fetal data visualization is enabled by this software.
Funding Insights of Neoventa
Neoventa has successfully raised a total of $8.1M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $8.1 million completed in July 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.1M
- Total Rounds 1
- Last Round Private Equity Round β $8.1M
- First Round $8.1M
(Jul 2006)
- Investors Count 3
All 1 funding rounds of Neoventa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2006 | $8.1M | Private Equity Round | β | β |
3 investors in total: 3 institutional.
Investors in Neoventa
Neoventa has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SEB, CapMan and Investor Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified investment management firm | 1989 | capman.com | Helsinki, Finland | |
Corporate-backed venture capital firm focused on fintech, energy, and multiple sectors | investorgrowthcapital.com | New York, United States | ||
Commercial banking services are provided to businesses in Nordic markets. | 1972 | seb.se | Stockholm, Sweden |
Investor details for Neoventa
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neoventa
11 people are tracked at Neoventa (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Fredrik Bäckström | Executive Vice President- Product | Leadership |
Janna Klein | COO | Leadership |
Christian Pitulia | CEO | Leadership |
Frida Svenningsson | Chief People Officer | Leadership |
Leif Broberg | Director Of Operations | Leadership |
Sofia Blad | Scientific And Clinical Director | Leadership |
Kingsly Anand A. | Quality Coordinator | Team |
Laura Goethals | Quality Engineer / Product Manager - Consumables & Accessories | Team |
Linnea Forsner | Project Manager | Team |
Anne-Elisabeth Helly | Sales Manager France | Team |
Johan Sundberg | CQRO | Team |
Complete people profiles for Neoventa
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neoventa
2 dated milestones of Neoventa across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Neoventa is founded.
- Funding First funding round of $8.1M.
Web traffic of Neoventa
The website of Neoventa (neoventa.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 52.4% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neoventa
Complete news archive for Neoventa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neoventa
Neoventa was founded in 1997 and raised its 1st funding round 9 years after it was founded.
Neoventa is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Neoventa is a funded company, having raised a total of $8.1M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $8.1M, raised on Jul 2006.
Fetal monitoring technologies are developed and distributed by Neoventa Medical AB. Focus is placed on continuous monitoring devices like Stan S41 for improved maternal and fetal safety. Solutions are offered across healthcare sectors in Europe, Middle East, Asia, and Africa. Training and educational resources through Neoventa Academy are also provided to support clinical practices.
Neoventa offers Stan S41, Goldtrace, and Stan Viewer.
Neoventa has 3 investors. Key investors include SEB, CapMan, and Investor Growth Capital.
Neoventa operates through Neoventa Medical Ab.
